findmyKOL
Clinical trialNCT01549834CompletedPhase 2Interventional

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

SponsorAbbVie (prior sponsor, Abbott)Enrollment434Alzheimer's Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Site Reference Id/investigator# 71793

    Gatineau, Canada

  • Site Reference Id/investigator# 71794

    Montreal, Canada

  • Site Reference Id/investigator# 71798

    Peterborough, Canada

  • Site Reference Id/investigator# 71795

    Toronto, Canada

  • Site Reference Id/investigator# 71796

    Verdun, Canada

France
  • Site Reference Id/investigator# 71573

    Dijon, France

  • Site Reference Id/investigator# 77833

    Limoges, France

  • Site Reference Id/investigator# 68704

    Paris, France

  • Site Reference Id/investigator# 68706

    Paris, France

  • Site Reference Id/investigator# 68705

    Toulouse, France

Germany
  • Site Reference Id/investigator# 68768

    Berlin, Germany

  • Site Reference Id/investigator# 68764

    Freiburg im Breisgau, Germany

  • Site Reference Id/investigator# 68767

    Hüttenberg, Germany

  • Site Reference Id/investigator# 69960

    Mittweida, Germany

  • Site Reference Id/investigator# 68765

    Munich, Germany

  • Site Reference Id/investigator# 69959

    Schwerin, Germany

Greece
  • Site Reference Id/investigator# 68730

    Athens, Greece

  • Site Reference Id/investigator# 68732

    Athens, Greece

  • Site Reference Id/investigator# 68733

    Athens, Greece

  • Site Reference Id/investigator# 68731

    Haidari, Athens, Greece

  • Site Reference Id/investigator# 68729

    Thessaloniki, Greece

  • Site Reference Id/investigator# 68735

    Thessaloniki, Greece

South Africa
  • Site Reference Id/investigator# 67586

    Belville, South Africa

  • Site Reference Id/investigator# 67582

    Cape Town, South Africa

  • Site Reference Id/investigator# 67584

    George, South Africa

  • Site Reference Id/investigator# 67585

    Johannesburg, South Africa

  • Site Reference Id/investigator# 67583

    Rosebank, South Africa

United Kingdom
  • Site Reference Id/investigator# 67787

    Bath, United Kingdom

  • Site Reference Id/investigator# 67784

    Glasgow, United Kingdom

  • Site Reference Id/investigator# 67786

    London, United Kingdom

  • Site Reference Id/investigator# 67785

    Manchester, United Kingdom

  • Site Reference Id/investigator# 67783

    Warrington, United Kingdom

United States
  • Site Reference Id/investigator# 66528

    Fresno, California, United States

  • Site Reference Id/investigator# 69602

    Long Beach, California, United States

  • Site Reference Id/investigator# 66527

    San Francisco, California, United States

  • Site Reference Id/investigator# 66530

    Hamden, Connecticut, United States

  • Site Reference Id/investigator# 66522

    Delray Beach, Florida, United States

  • Site Reference Id/investigator# 66524

    Orlando, Florida, United States

  • Site Reference Id/investigator# 66531

    Tampa, Florida, United States

  • Site Reference Id/investigator# 66529

    West Palm Beach, Florida, United States

3 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2012
Primary completion
31 Oct 2013
Completion
31 Oct 2013
Last update posted
31 Oct 2014
Registered enrollment
434
Registry id
NCT01549834

Cross-registrations

EU-CTR / CTIS (EudraCT)2011-004849-40
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.